● Johnson & Johnson
Johnson & Johnson was founded in 1886 and is headquartered in New Jersey and New Brunswick, USA. Johnson & Johnson is a multinational biotechnology company, and manufacturer of consumer packaged products and medical devices. The company distributes and sells more than 172 drugs in the United States. The collaborating pharmaceutical divisions focus on infectious diseases, immunology, oncology and neuroscience. In 2015, Qiangsheng had 126,500 employees, total assets of $131 billion, and sales of $74 billion.
● Roche
Roche Biotech was founded in Switzerland in 1896. It has 14 biopharmaceutical products on the market and bills itself as the world's largest biotech partner. Roche had total sales of $51.6 billion in 2015, a market value of $229.6 billion, and 88,500 employees.
● Novartis
Novartis was formed in 1996 from the merger of Sandoz and Ciba-Geigy. The company manufactures pharmaceuticals, generics and eye care products. The company's business covers the growing markets of emerging markets in Latin America, Asia and Africa. Novartis Healthcare is a world leader in development and primary care, and commercialization of specialty medicines. In 2015, Novartis had more than 133,000 employees worldwide, assets of $225.8 billion, and sales of $53.6 billion.
● Pfizer
Pfizer is a global biotechnology company founded in 1849 and headquartered in New York City, USA. It bought Botox Maker Allergan for $160 million in 2015, the largest-ever deal in the medical space. In 2015, Pfizer had assets of $169.3 billion and sales of $49.6 billion.
● Merck
Merck was founded in 1891 and is headquartered in New Jersey, USA. It is a worldwide company that manufactures prescription drugs, biotherapeutics, vaccines, as well as animal health and consumer products. Merck has invested heavily in fighting emerging pandemics, including Ebola. In 2015, Merck had a market capitalization of about $150 billion, sales of $42.2 billion, and assets of $98.3 billion.
● Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company dedicated to the discovery, development and commercialization of innovative medicines, headquartered in California, USA. In 2015, Gilead Sciences had $34.7 billion in assets and $25 billion in sales.
● Novo Nordisk
Novo Nordisk is a multinational biotechnology company headquartered in Denmark, with manufacturing facilities in 7 countries and 41,000 employees and offices in 75 countries around the world. In 2015, Novo Nordisk had assets of $12.5 billion and sales of $15.8 billion.
● Amgen
Amgen, headquartered in Thousand Oaks, California, manufactures therapeutics and focuses on developing new medicines based on advances in molecular and cellular biology. The company develops treatments for bone disease, kidney disease, rheumatoid arthritis and other serious conditions. In 2015, Amgen had assets of $69 billion and sales of $20 billion.
● Bristol-Myers Squibb
Bristol-Myers Squibb (Bristol) is a biotechnology company headquartered in New York City, United States. Bristol-Myers Squibb bought iPierian for $725 million in 2015 and Flexus Biosciences for $125 million in 2015. In 2015, Bristol-Myers Squibb had assets of $33.8 billion and sales of $15.9 billion.
● Sanofi
Sanofi is a French pharmaceutical partnership company headquartered in Paris. The company specializes in human vaccines, diabetes solutions and consumer healthcare, innovative medicines and other products. Sanofi operates in more than 100 countries around the world, including the United States, with its U.S. headquarters in Bridgewater, New Jersey. In 2015, Sanofi had total assets of $177.9 billion and sales of $44.8 billion.
Post time: Jan-22-2019